SCHEMBL3866841

SCHEMBL3866841

Cc1cc(C(=O)Nc2cc(N3CCN(C)CC3)ccc2C(=O)Nc2n[nH]c3sc(C(=O)O)cc23)n[nH]1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALK Q9UM73 15/20 0.44
INSR P06213 14/20 0.44
FGFR1 P11362 2/20 0.43
IGF1R P08069 9/20 0.43
SIRT6 Q8N6T7 1/20 0.42
AURKA O14965 3/20 0.42
AURKB Q96GD4 2/20 0.42
PLK4 O00444 1/20 0.40
DAPK3 O43293 1/20 0.40
NTRK1 P04629 1/20 0.40
PRKCG P05129 1/20 0.40
ROS1 P08922 1/20 0.40
FER P16591 1/20 0.40
LTK P29376 1/20 0.40
WEE1 P30291 1/20 0.40
FRK P42685 1/20 0.40
MAPK8 P45983 1/20 0.40
MST1R Q04912 1/20 0.40
PTK2 Q05397 1/20 0.40
TNK2 Q07912 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1779217 0.88 AURKA (0.55) ALKINSRFGFR1IGF1RSIRT6
SCHEMBL3868337 0.86 CSF1R (0.45) ALKINSRFGFR1IGF1RAURKA
SCHEMBL3868170 0.85 IGF1R (0.56) ALKINSRIGF1RSIRT6AURKA
SCHEMBL1779993 0.85 AURKA (0.45) ALKINSRIGF1RSIRT6AURKA
SCHEMBL3865316 0.84 INSR (0.48) ALKINSRFGFR1IGF1RAURKA
SCHEMBL3872622 0.83 ALK (0.42) ALKINSRFGFR1IGF1RAURKA
SCHEMBL3871624 0.83 ALK (0.42) ALKINSRFGFR1IGF1RAURKA
SCHEMBL3872625 0.83 ALK (0.42) ALKINSRFGFR1IGF1RAURKA
SCHEMBL3868697 0.83 INSR (0.43) ALKINSRFGFR1IGF1RAURKA
SCHEMBL1777648 0.83 ALK (0.38) ALKINSRFGFR1IGF1RSIRT6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904503-B1 1H-THIENO[2,3-C]-PYRAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES SRL (IT) 2013-11-06 EP claimed
US-20090149457-A1 1H-Thieno[2,3-c]Pyrazole Compounds Useful as Kinase Inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-06-11 US claimed
EP-1904503-A1 1H-THIENO[2,3-C]-PYRAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2008-04-02 EP claimed
WO-2007009898-A1 1H-THIENO[2,3-C]PYRAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2007-01-25 WO claimed
EP-1904503-B1 1H-THIENO[2,3-C]-PYRAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES SRL (IT) 2013-11-06 EP disclosed
US-20090149457-A1 1H-Thieno[2,3-c]Pyrazole Compounds Useful as Kinase Inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2009-06-11 US disclosed
EP-1904503-A1 1H-THIENO[2,3-C]-PYRAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.r.l. (IT) 2008-04-02 EP disclosed
WO-2007009898-A1 1H-THIENO[2,3-C]PYRAZOLE COMPOUNDS USEFUL AS KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2007-01-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090149457-A1 1H-Thieno[2,3-c]Pyrazole Compounds Useful as Kinase Inhibitors CCNH, PDK1, MAP3K5 ALK 423/4885INSR 1010/4885FGFR1 180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.